PYOC Cardiology Profile picture
Dec 7, 2020 14 tweets 4 min read
➡️Yes, this combo improved Sxs & reduced CVD death & hosp rates (click here) 💯Correct!

⚡️The HYD/ISDN combo was tested in the A-HeFT trial in an all-AA population with HFrEF.

⚡️More than 80% also had T2D & ~34% had renal insufficiency.

⭐️The vasodilator combo showed improvements in Sxs & reductions in hosp & CVD death rates. Image